Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 572-580

  Chee, Jonathan ^a,b   Ko, Hyun Ja ^c   Skowera, Ania ^d   Jhala, Gaurang ^a,b   Catterall, Tara ^a   Graham, Kate L ^a,b   Sutherland, Robyn M ^c   Thomas, Helen E ^a,b   Lew, Andrew M ^c   Peakman, Mark ^d   Kay, Thomas W H ^a,b   Krishnamurthy, Balasubramanian ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN; INTERLEUKIN 7 RECEPTOR ALPHA; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY G MEMBER 1; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPH NODE; LYMPHOCYTE MIGRATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; SPLEEN;

ANIMALS; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; GLUCOSE-6-PHOSPHATASE; IMMUNOLOGIC MEMORY; ISLETS OF LANGERHANS; LYMPHOCYTES; MICE; MICE, INBRED NOD;

EID: 84892686874     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302100     Document Type: Article

References (34)

1. Mannering, S. I., F. S. Wong, I. Durinovic-Belló, B. Brooks-Worrell, T. I. Tree, C. M. Cilio, N. C. Schloot, and R. Mallone; Immunology of Diabetes Society T-Cell Workshop Committee. 2010. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin. Exp. Immunol. 162: 197-209.
2. Skowera, A., R. J. Ellis, R. Varela-Calviño, S. Arif, G. C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J. S. Allen, T. I. Tree, et al. 2008. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucoseregulated preproinsulin epitope. J. Clin. Invest. 118: 3390-3402.
3. Published erratum appears in 2009 J. Clin. Invest. 119: 2844.
4. Velthuis, J. H., W. W. Unger, J. R. Abreu, G. Duinkerken, K. Franken, M. Peakman, A. H. Bakker, S. Reker-Hadrup, B. Keymeulen, J. W. Drijfhout, et al. 2010. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59: 1721-1730.
5. Reijonen, H., R. Mallone, A. K. Heninger, E. M. Laughlin, S. A. Kochik, B. Falk, W. W. Kwok, C. Greenbaum, and G. T. Nepom. 2004. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53: 1987-1994. (Pubitemid 38970746)
6. Takahashi, K., M. C. Honeyman, and L. C. Harrison. 2001. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin. Immunol. 99: 360-364.
7. Danke, N. A., J. Yang, C. Greenbaum, and W. W. Kwok. 2005. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25: 303-311. (Pubitemid 41642977)
8. Driver, J. P., D. V. Serreze, and Y. G. Chen. 2011. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin. Immunopathol. 33: 67-87.
9. Trudeau, J. D., C. Kelly-Smith, C. B. Verchere, J. F. Elliott, J. P. Dutz, D. T. Finegood, P. Santamaria, and R. Tan. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111: 217-223. (Pubitemid 36105920)
10. Graham, K. L., B. Krishnamurthy, S. Fynch, Z. U. Mollah, R. Slattery, P. Santamaria, T. W. Kay, and H. E. Thomas. 2011. Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes. Am. J. Pathol. 178: 2716-2725.
11. Chong, M. M., Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. Kay, and H. E. Thomas. 2004. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J. Immunol. 172: 5714-5721. (Pubitemid 38542076)
12. Chee, J., E. Angstetra, L. Mariana, K. L. Graham, E. M. Carrington, H. Bluethmann, P. Santamaria, J. Allison, T. W. Kay, B. Krishnamurthy, and H. E. Thomas. 2011. TNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic mice. J. Immunol. 187: 1702-1712.
13. French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, and A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46: 34-39. (Pubitemid 27009946)
14. Krishnamurthy, B., N. L. Dudek, M. D. McKenzie, A. W. Purcell, A. G. Brooks, S. Gellert, P. G. Colman, L. C. Harrison, A. M. Lew, H. E. Thomas, and T. W. Kay. 2006. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116: 3258-3265. (Pubitemid 44878640)
15. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676. (Pubitemid 27506280)
16. Moon, J. J., H. H. Chu, J. Hataye, A. J. Pagán, M. Pepper, J. B. McLachlan, T. Zell, and M. K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4: 565-581.
17. Nakayama, M., J. N. Beilke, J. M. Jasinski, M. Kobayashi, D. Miao, M. Li, M. G. Coulombe, E. Liu, J. F. Elliott, R. G. Gill, and G. S. Eisenbarth. 2007. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J. Clin. Invest. 117: 1835-1843. (Pubitemid 47036317)
18. McKenzie, M. D., E. Jamieson, E. S. Jansen, C. L. Scott, D. C. Huang, P. Bouillet, J. Allison, T. W. Kay, A. Strasser, and H. E. Thomas. 2010. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 59: 644-652.
19. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161: 5338-5346. (Pubitemid 28519094)
20. Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286: 1377-1381.
21. Homann, D., L. Teyton, and M. B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7: 913-919. (Pubitemid 32756428)
22. Obar, J. J., and L. Lefrançois. 2010. Early events governing memory CD8+ T-cell differentiation. Int. Immunol. 22: 619-625.
23. Thimme, R., V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79: 12112-12116. (Pubitemid 41279330)
24. Wirth, T. C., H. H. Xue, D. Rai, J. T. Sabel, T. Bair, J. T. Harty, and V. P. Badovinac. 2010. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33: 128-140.
25. Jabbari, A., and J. T. Harty. 2006. Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. J. Exp. Med. 203: 919-932.
26. Vezys, V., A. Yates, K. A. Casey, G. Lanier, R. Ahmed, R. Antia, and D. Masopust. 2009. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196-199.
27. Gründemann, C., M. Bauer, O. Schweier, N. von Oppen, U. Lässing, P. Saudan, K. F. Becker, K. Karp, T. Hanke, M. F. Bachmann, and H. Pircher. 2006. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J. Immunol. 176: 1311-1315. (Pubitemid 43134270)
28. Prlic, M., J. A. Sacks, and M. J. Bevan. 2012. Dissociating markers of senescence and protective ability in memory T cells. PLoS ONE 7: e32576.
29. Masopust, D., S. J. Ha, V. Vezys, and R. Ahmed. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177: 831-839. (Pubitemid 44036583)
30. Tan, J. T., B. Ernst, W. C. Kieper, E. LeRoy, J. Sprent, and C. D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195: 1523-1532. (Pubitemid 34666066)
31. Lee, L. F., K. Logronio, G. H. Tu, W. Zhai, I. Ni, L. Mei, J. Dilley, J. Yu, A. Rajpal, C. Brown, et al. 2012. Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc. Natl. Acad. Sci. USA 109: 12674-12679.
32. Penaranda, C., W. Kuswanto, J. Hofmann, R. Kenefeck, P. Narendran, L. S. Walker, J. A. Bluestone, A. K. Abbas, and H. Dooms. 2012. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc. Natl. Acad. Sci. USA 109: 12668-12673.
33. Coppieters, K., N. Amirian, and M. von Herrath. 2012. Intravital imaging of CTLs killing islet cells in diabetic mice. J. Clin. Invest. 122: 119-131.
34. Bulek, A. M., D. K. Cole, A. Skowera, G. Dolton, S. Gras, F. Madura, A. Fuller, J. J. Miles, E. Gostick, D. A. Price, et al. 2012. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat. Immunol. 13: 283-289.